IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
IAVI partners with more than
50 academic, biotechnology,
pharmaceutical and governmental
institutions to develop AIDS
vaccines, and to advocate for
the HIV-prevention field.
IAVI is working with partners to
ensure that once a preventive
AIDS vaccine is developed,
it will be available to those
who need it most.
As researchers make significantprogress toward the development ofan AIDS vaccine, new modeling datahighlights its potentially striking impact.
This report details key activities in 2011 that support IAVI's mission to develop a safe, effective accessible, preventive HIV vaccine for use throughout the world.
The report of a child functionally cured of HIV stirred up the typically staid proceedings of the Conference on Retroviruses and Opportunistic Infections.
VAX is the bulletin on AIDS vaccine research for you.
International AIDS Vaccine Initiative. All rights reserved. International AIDS Vaccine Initiative, IAVI and the IAVI logo are trademarks of the International AIDS Vaccine Initiative, Inc.